Company intelligence / Profile preview

HoloTwin

Paris, Île-de-France, France

Ownership: Private
Development stage: Other

Overview

HoloTwin is a digital health company that leverages artificial intelligence and biological modeling to create digital twins of patients. These virtual models are used to simulate drug responses, optimize clinical trial designs, and accelerate the development of personalized therapies. By integrating multi-omics data and clinical parameters, the company's platform aims to reduce the time and cost of drug discovery while improving patient outcomes. The technology is particularly focused on providing predictive insights for complex diseases such as cancer and cardiovascular conditions.

Therapeutic areas: OncologyNeurologyCardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Drug Discovery Services

Beyond the preview

Go deeper on HoloTwin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HoloTwin.

Explore the full profile